Results 191 to 200 of about 151,232 (337)
von Willebrand disease type1/type 2N compound heterozygotes: diagnostic and management challenges [PDF]
Juliana Perez Botero +4 more
openalex +1 more source
von Willebrand Disease: A Concise Review and Update for the Practicing Physician
Arjun Swami, V. Kaur
semanticscholar +1 more source
ABSTRACT Background Large B‐cell lymphomas (LBCLs) are a common subtype of non‐Hodgkin lymphomas. CD19 chimeric antigen receptor T‐cell (CAR‐T) therapy has revolutionized LBCL treatment, with high remission rates but also significant toxicities, including cytokine release syndrome (CRS) and immune effector cell‐associated neurotoxicity syndrome (ICANS).
Neha Venkatesh +9 more
wiley +1 more source
von Willebrand disease combined with other hemostasis disorders: an overlooked clinical entity. [PDF]
Seidizadeh O, Mannucci PM, Peyvandi F.
europepmc +1 more source
The impact of bleeding history, von Willebrand factor and PFA–100® on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM‐1VWD [PDF]
Giancarlo Castaman +16 more
openalex +1 more source
Beyond lipids: Systemic effects of lipoprotein apheresis
Transfusion, EarlyView.
Menatalla Nadim, Yamac Akgun
wiley +1 more source
Treadmill training protects against white matter injury and reduces cerebral infarction. Muscle‐derived mitochondrial transfer via platelets is promoted by treadmill training. Platelet transfusion emerges as a potential low‐risk therapeutic strategy for sequelae and vascular dementia.
Toshiki Inaba +8 more
wiley +1 more source
Managing Anesthesia for a Patient With Von Willebrand Disease: A Case Report. [PDF]
Singavarapu J, Borodulina G.
europepmc +1 more source
Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor. [PDF]
H R Grainick +6 more
openalex +1 more source

